Rxsight Inc News Today

ZUG, Switzerland, May 30, 2024 -- Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members...

The Medical Instruments industry has been witnessing a gradual transition from remote healthcare and contactless services during the pandemic to its original space of point-of-care testing, heavy as well as minimally invasive implants, elective procedures, and so on. This industry is highly fragmented, with participants engaged in research and development (R&D) in therapeutic areas.

RxSight, Inc. (NASDAQ:RXST – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have updated their coverage on the stock in the last […]

Lisanti Capital Growth LLC lessened its position in RxSight, Inc. (NASDAQ:RXST – Free Report) by 10.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 110,820 shares of the company’s stock after selling 12,385 shares during the quarter. Lisanti Capital Growth LLC […]

ALISO VIEJO, Calif., May 06, 2024 -- – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today...

RxSight, Inc. (NASDAQ:RXST – Get Free Report) has been given a consensus recommendation of “Buy” by the six analysts that are currently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock in the […]

ALISO VIEJO, Calif., April 22, 2024 -- – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today...

RxSight, Inc. (NASDAQ:RXST – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the last […]

ALISO VIEJO, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- RXST – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality…

RxSight, Inc. (NASDAQ:RXST – Get Free Report) CFO Shelley B. Thunen sold 20,000 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $49.90, for a total transaction of $998,000.00. Following the completion of the sale, the chief financial officer now directly owns 8,402 shares […]